Summary
- Current Price
- As of today, CCCC price is $3.87, up +6.91% on
- Current Price All-Time High
- CCCC price is currently -92.44% below its historical high of $51.21 set on
- Market Cap
- CCCC current market cap is $428M, up +149.01% over the past 365 days
- Revenue
- CCCC current annual revenue is $35.95M, up +1.02% year-over-year
- Next Earnings
- The next earnings release for CCCC is on
Profile
| Metric | Value |
|---|---|
| Full Name | C4 Therapeutics, Inc. |
| Ticker | NASDAQ: CCCC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | c4therapeutics.com |
| Employees | 110 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $3.87 | ||
| Price, 1D Change | +6.91% | |
| $428M | ||
| - | ||
| - | ||
| 1.95 | ||
| $35.95M | ||
| Revenue, 1Y Change | +1.02% | |
| -$1.27 | ||
| EPS, 1Y Change | +16.57% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | -$0.96 | N/A |
| EPS Est. Change | +24.52% | N/A |
| $35.95M | ||
| Revenue Estimate | $18.93M | N/A |
| Revenue Est. Change | -47.35% | N/A |
| $3.87 | ||
| Price Target | $11.00 | - |
| Price Tgt. Change | +184.24% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.31 | -$1.52 | -15.76% | |
| -$1.52 | -$1.27 | +16.67% | |
| -$0.96 | N/A | +24.52% | |
| -$1.04 | N/A | +17.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $35.77M | $35.58M | -0.53% | |
| $30.39M | $35.95M | +18.29% | |
| $18.93M | N/A | -47.35% | |
| $19.14M | N/A | -46.75% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +59.92% | ||
| +13.49% | ||
| +149.01% | ||
| +155.75% | ||
| +1.02% | ||
| +15.60% | ||
| +16.57% | ||
| +51.72% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $3.87 | ||
| $2.90 | ||
| $3.91 | ||
| $3.17 | ||
| $3.71 | ||
| -$0.05 | ||
| 1.95 | ||
| $0.25 | ||
| 54.45 | ||
| 54.34% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $35.95M | ||
| -$1.27 | ||
| $0.00 | ||
| 77.81% | ||
| -$104.49M | ||
| -290.68% | ||
| -$104.99M | ||
| -292.08% | ||
| -$96.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.23 | ||
| 7.81 | ||
| 7.81 | ||
| - | ||
| 3 | ||
| 0.27 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 12.27 | ||
| 1.83 | ||
| -2.63 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $256.59M | ||
| $248.54M | ||
| $371.94M | ||
| $258.11M | ||
| $115.35M | ||
| $33.03M | ||
| $59.98M | ||
| $6.37M | ||
| $858.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $140.94M | ||
| $132.46M | ||
| $7.98M | ||
| $36.20M | ||
| $8.39M | ||
| $0.00 | ||
| $121.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$98.69M | ||
| -$8.60M | ||
| $126.40M | ||
| $607.00K | ||
| -$99.30M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Evercore ISI Group | → | |
| Barclays | → | |
| Brookline Capital | → | |
| Barclays | → | |
| TD Cowen | ||
| Wells Fargo | → | |
| Barclays | → | |
| Stephens & Co. | → | |
| Barclays | ||
| Stephens & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CCCC
FAQ
- What is the ticker symbol for C4 Therapeutics, Inc.?
- The ticker symbol for C4 Therapeutics, Inc. is NASDAQ:CCCC
- Does C4 Therapeutics, Inc. pay dividends?
- No, C4 Therapeutics, Inc. does not pay dividends
- What sector is C4 Therapeutics, Inc. in?
- C4 Therapeutics, Inc. is in the Healthcare sector
- What industry is C4 Therapeutics, Inc. in?
- C4 Therapeutics, Inc. is in the Biotechnology industry
- What country is C4 Therapeutics, Inc. based in?
- C4 Therapeutics, Inc. is headquartered in United States
- When did C4 Therapeutics, Inc. go public?
- C4 Therapeutics, Inc. initial public offering (IPO) was on October 2, 2020
- Is C4 Therapeutics, Inc. in the S&P 500?
- No, C4 Therapeutics, Inc. is not included in the S&P 500 index
- Is C4 Therapeutics, Inc. in the NASDAQ 100?
- No, C4 Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is C4 Therapeutics, Inc. in the Dow Jones?
- No, C4 Therapeutics, Inc. is not included in the Dow Jones index
- When was C4 Therapeutics, Inc. last earnings report?
- C4 Therapeutics, Inc.'s most recent earnings report was on May 12, 2026
- When does C4 Therapeutics, Inc. report earnings?
- The next expected earnings date for C4 Therapeutics, Inc. is August 11, 2026
Data Sources & References
- CCCC Official Website www.c4therapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1662579/000162828026012000/0001628280-26-012000-index.htm
- CCCC Profile on Yahoo Finance finance.yahoo.com/quote/CCCC
- CCCC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cccc